Edina, MN (BUSINESS WIRE) - (Feb 6, 2008) – Tornier, Inc., a global leader in
extremities orthopedics, announced today that it has entered into an
exclusive world-wide technology collaboration in the field of orthopedic soft
tissue repair with BioSurface Engineering Technologies, Inc. ("BioSET") to
develop, commercialize, and distribute products that will incorporate
BioSET’s synthetic growth factor technology. The collaboration will focus
initially on ligament and tendon repair products that will feature coatings
based on BioSET’s proprietary F2A synthetic growth factor technology
(“F2A”).
Doug Kohrs, President and Chief Executive Officer of Tornier commented
“Effective orthopedic soft tissue repair remains an unsolved problem,
especially in rotator cuff and other ligament and tendon injuries. Our
collaboration with BioSET evidences Tornier’s long term commitment to
innovative biologic and synthetic materials to improve clinical outcomes for
both hard tissue and soft tissue orthopedic repair procedures.”
The BioSET F2A peptide is a synthetic mimetic of the natural human FGF-2
growth factor. FGF-2 and other naturally occurring growth factors are known
to play key roles in the body’s healing and repair processes. Synthetic
growth factor mimetics may address many of the manufacturing, handling,
and shelf life challenges that have limited the clinical role of natural growth
factors. One of a family of BioSET developed and patented synthetic growth
factor mimetics, F2A has been the subject of several published animal
studies that have evidenced the peptide’s FGF-2 mimetic activity.
About Tornier
Tornier develops and markets orthopedic medical devices designed to
restore function and return patients to an active and healthy lifestyle. The
company's innovative extremity products include the Aequalis® line of
shoulder arthroplasty prostheses, the Salto™ and Salto Talaris™ total ankle
prosthesis, and a broad portfolio of foot and hand products resulting from its
acquisitions of Nexa Orthopedics and DVO Extremity Solutions. In addition
to its acquisitions, Tornier has established collaborations with ompanies
such as Bioretec and Tepha Medical in order to access innovative non-metal
technologies that may better address unmet soft and hard tissue repair
needs of orthopedic surgeons and their patients.
For more information regarding Tornier, visit www.tornier-us.com. |
